Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1232690

Examining the activation status of OCRL inhibited platelets by flow cytometry


Bura, Ana; Jurak Begonja, Antonija
Examining the activation status of OCRL inhibited platelets by flow cytometry // N/A
online, 2021. str. N/A-N/A (predavanje, međunarodna recenzija, ostalo, znanstveni)


CROSBI ID: 1232690 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Examining the activation status of OCRL inhibited platelets by flow cytometry

Autori
Bura, Ana ; Jurak Begonja, Antonija

Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, ostalo, znanstveni

Izvornik
N/A / - , 2021, N/A-N/A

Skup
ICGEB course Flow cytometry: from basic principles to advanced application CytoFlow@ICGEB

Mjesto i datum
Online, 28.-30. 09. 2021

Vrsta sudjelovanja
Predavanje

Vrsta recenzije
Međunarodna recenzija

Ključne riječi
OCRL, platelets, p-selectin, integrin, flow cytometry

Sažetak
We researched the involvement of phosphoinositides in the development and function of the smallest blood cells, platelets. In particular, I investigate phosphatidylinositol-4-monophosphate (PI4P), phosphatidylinositol-4, 5-bisphosphate [PI(4, 5)P2], and the oculocerebrorenal syndrome of Lowe protein (OCRL) that dephosphorylates PI(4, 5)P2 to PI4P. Mutations in OCRL cause Lowe syndrome, which is characterized by a triade of symptoms affecting the brain, the eyes, and the kidneys, but it has also been shown that these patients have problems with bleedings suggesting platelet (PLT) disfunction. We started our research by inhibiting OCRL and examining the spreading ability of human and mouse PLTs by immunocytochemistry, then we moved on to researching signalling pathways in human PLTs that OCRL might be affecting and we preliminary characterized megakaryocytes and PLTs from OCRL KO mice by several different methods. The next step was to analyze how OCRL affects PLT function upon activation with different agonists by flow cytometry. We started by inhibiting PLTs for OCRL and activating them with a thrombin mimetic, staining for two PLT activation markers and examining them by flow cytometry.

Izvorni jezik
Engleski

Znanstvena područja
Biotehnologija u biomedicini (prirodno područje, biomedicina i zdravstvo, biotehničko područje)



POVEZANOST RADA


Ustanove:
Sveučilište u Rijeci - Odjel za biotehnologiju

Profili:

Avatar Url Ana Bura (autor)

Avatar Url Antonija Jurak Begonja (autor)


Citiraj ovu publikaciju:

Bura, Ana; Jurak Begonja, Antonija
Examining the activation status of OCRL inhibited platelets by flow cytometry // N/A
online, 2021. str. N/A-N/A (predavanje, međunarodna recenzija, ostalo, znanstveni)
Bura, A. & Jurak Begonja, A. (2021) Examining the activation status of OCRL inhibited platelets by flow cytometry. U: N/A.
@article{article, author = {Bura, Ana and Jurak Begonja, Antonija}, year = {2021}, pages = {N/A-N/A}, keywords = {OCRL, platelets, p-selectin, integrin, flow cytometry}, title = {Examining the activation status of OCRL inhibited platelets by flow cytometry}, keyword = {OCRL, platelets, p-selectin, integrin, flow cytometry}, publisherplace = {online} }
@article{article, author = {Bura, Ana and Jurak Begonja, Antonija}, year = {2021}, pages = {N/A-N/A}, keywords = {OCRL, platelets, p-selectin, integrin, flow cytometry}, title = {Examining the activation status of OCRL inhibited platelets by flow cytometry}, keyword = {OCRL, platelets, p-selectin, integrin, flow cytometry}, publisherplace = {online} }




Contrast
Increase Font
Decrease Font
Dyslexic Font